
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.14 | 2.14 | 0.00 |
Shares | 99.82 | 99.82 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.97 | 18.94 |
Price to Book | 3.61 | 4.24 |
Price to Sales | 4.20 | 2.33 |
Price to Cash Flow | 13.35 | 15.92 |
Dividend Yield | 0.90 | 1.17 |
5 Years Earnings Growth | 23.06 | 11.59 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 96.85 | 99.61 |
Basic Materials | 3.15 | 1.02 |
Number of long holdings: 71
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 9.18 | 189.99 | +2.35% | |
Amgen | US0311621009 | 6.07 | 290.52 | +4.05% | |
Gilead | US3755581036 | 5.03 | 111.76 | +0.80% | |
Vertex | US92532F1003 | 4.17 | 452.16 | +1.56% | |
Corteva | US22052L1044 | 3.15 | 75.11 | +0.78% | |
Regeneron Pharma | US75886F1075 | 3.02 | 534.67 | +1.84% | |
Alnylam | US02043Q1076 | 2.71 | 322.06 | -1.24% | |
AstraZeneca ADR | US0463531089 | 2.48 | 71.47 | +2.28% | |
Illumina | US4523271090 | 2.44 | 98.15 | +2.87% | |
Biogen | US09062X1037 | 2.23 | 130.07 | +3.57% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Rydex NASDAQ-100 Inv | 1.68B | 1.32 | 18.59 | 16.42 | ||
Rydex S&P 500 H | 139.75M | 26.17 | 9.59 | 11.44 | ||
Rydex Variable NASDAQ 100 2x Strate | 160.78M | -3.44 | 27.04 | 26.20 | ||
Rydex Variable NASDAQ 100 | 128.12M | 2.10 | 11.82 | 16.98 | ||
Rydex NASDAQ 100 Fund Class A | 123.68M | 23.67 | 8.32 | 16.38 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review